Friday, Apr 19, 2024
logo
Update At 14:00    USD/EUR 0,94  ↑+0.0007        USD/JPY 154,32  ↓-0.276        USD/KRW 1.382,94  ↑+5.38        EUR/JPY 164,11  ↓-0.422        Crude Oil 88,63  ↑+1.52        Asia Dow 3.680,88  ↑+19.64        TSE 1.802,00  ↓-6.5        Japan: Nikkei 225 37.156,27  ↓-923.43        S. Korea: KOSPI 2.591,03  ↓-43.67        China: Shanghai Composite 3.062,00  ↓-12.2286        Hong Kong: Hang Seng 16.184,02  ↓-201.85        Singapore: Straits Times 3,19  ↓-0.016        DJIA 22,13  ↓-0.067        Nasdaq Composite 15.601,50  ↓-81.873        S&P 500 5.011,12  ↓-11.09        Russell 2000 1.942,96  ↓-4.992        Stoxx Euro 50 4.936,57  ↑+22.44        Stoxx Europe 600 499,70  ↑+1.18        Germany: DAX 17.837,40  ↑+67.38        UK: FTSE 100 7.877,05  ↑+29.06        Spain: IBEX 35 10.765,00  ↑+131.1        France: CAC 40 8.023,26  ↑+41.75        

Leader Database

Osamu Maeda

Position

President

Company Name

Zeal Cosmetics, Inc.

Bio

Osamu Maeda founded Zeal Cosmetics Inc. in 2011, which became the leading skin care company in the beauty professional market in Japan. His collaboration study with Professor Tsukamoto of Kyoto Prefectural University created the world's first ostrich antibody ingredient. The revolutionary commercialization of this technology to protect and improve the overall welfare and health of humans, in particular from a beauty and healthcare aspect, has made Zeal into a cosmetics and total lifestyle solution group.

Information

Experience

Osamu Maeda started his business career as a contract salesman; he was often awarded for his achievement as the nation’s top sales person for numerous companies. In 2003, he began his entrepreneurship in the field of food manufacturing and IT marketing, such as mobile CRM solutions. In 2008, he began commercializing, buying and selling intellectual properties, focusing on advanced technologies researched and developed in Japan.

He continued dealing with various industries, such as food, health supplements, food chemicals/additives, LED, lactic acid bacteria, and others, to create new business opportunities, including one patent that generated over $10 billion annual revenue.

With this success he also began venturing into international business, beginning with partnerships in the USA, China, Indonesia, and the Philippines, dealing with health care, real estate, finance, IT and F&B industries.

In 2008, he met Professor Tsukamoto and started the business development of ostrich antibodies. After years of research and development, he established Zeal Cosmetics Inc., in 2011, and began the development of skin care products with the revolutionary and exclusive ostrich antibody ingredient.